Ambuja Cements Limited (AMBUJACEM.NS)
Mumbai, IN
Ambuja Cements Limited, including its subsidiaries, is a leading Indian entity engaged in the production and sale of cement and related building materials. The company serves a diverse customer base throughout India, targeting individual homeowners, masons, contractors, architects, and engineers. Its product portfolio encompasses Portland pozzolana cement, ordinary Portland cement, temperature-resistant concrete blocks, Blaine Portland cement, and various micro-materials. These products are distributed via an extensive network that includes dealers, authorized retail stockists, general retailers, and authorized sales representatives. Established in 1981 and based in Mumbai, India, the firm was formerly known as Gujarat Ambuja Cements Limited, adopting its current name in April 2007. Ambuja Cements Limited operates as a subsidiary of Holderind Investments Ltd.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.16% | -4.22% | -3.94% | -19.74% | -23.98% | -23.13% | -21.05% | +4.30% | +38.38% | +93.51% | +218.90% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 8 | 0 |
| Buy | 24 | 0 |
| Hold | 10 | +2 |
| Sell | 2 | 0 |
| Strong Sell | 1 | +1 |
-
Revenue growth Construction Materials: +2.8%+21.2% ★ Q1'26: +15.0% (vs Q1'25)
-
EPS growth Construction Materials: +14.1%+12.3% Q1'26: +89.9% (vs Q1'25)
-
FCF margin FCF growth · Construction Materials: +32.9%+7.0% ★ Q1'26: -19.4% (vs Q1'25)
-
EBIT margin Construction Materials: +9.5%+6.3% Q1'26: +2.7% (vs Q1'25)
-
ROIC Construction Materials: +5.1%+3.6% Q1'26: +1.7% (vs Q1'25)
-
Share dilution Construction Materials: +0.0%+1.0% Q1'26: +0.8% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Construction Materials: 0.56×0.14× ★ Q1'26: 0.16× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2011 actual |
Mar 2012 actual |
Mar 2013 actual |
Mar 2014 actual |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 35 Rev. Ana. 35 EPS Ana. |
Mar 2027 38 Rev. Ana. 36 EPS Ana. |
Mar 2028 36 Rev. Ana. 34 EPS Ana. |
Mar 2029 18 Rev. Ana. 16 EPS Ana. |
Mar 2030 18 Rev. Ana. 18 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
84.05B
est: 77.07B (+9.1%)
|
96.41B
est: 85.13B (+13.2%)
|
90.52B
est: 99.77B (-9.3%)
|
98.64B
est: 88.95B (+10.9%)
|
93.14B
est: 106.86B (-12.8%)
|
198.50B
est: 96.31B (+106.1%)
|
230.97B
est: 97.33B (+137.3%)
|
254.19B
est: 103.26B (+146.2%)
|
271.04B
est: 258.54B (+4.8%)
|
269.43B
est.
|
240.94B
est: 235.32B (+2.4%)
|
285.48B
est: 300.75B (-5.1%)
|
309.83B
est: 199.03B (+55.7%)
|
325.30B
est: 188.70B (+72.4%)
|
333.62B
est: 351.92B (-5.2%)
|
416.12B
401.81B – 446.57B
+18.2% YoY
|
465.02B
457.54B – 532.16B
+11.8% YoY
|
514.56B
476.32B – 579.42B
+10.7% YoY
|
559.14B
533.07B – 634.50B
+8.7% YoY
|
668.19B
637.04B – 758.25B
+19.5% YoY
|
| EBITDA |
22.01B
est: 23.77B (-7.4%)
|
25.42B
est: 23.80B (+6.8%)
|
20.70B
est: 27.67B (-25.2%)
|
23.53B
est: 24.35B (-3.4%)
|
18.95B
est: 27.45B (-31.0%)
|
36.22B
est: 24.97B (+45.0%)
|
41.96B
est: 42.80B (-2.0%)
|
42.46B
est: 40.61B (+4.5%)
|
45.88B
est: 42.26B (+8.6%)
|
37.18B
est.
|
52.96B
est: 43.42B (+22.0%)
|
64.66B
est: 52.59B (+23.0%)
|
42.18B
est: 55.16B (-23.5%)
|
78.08B
est: 33.32B (+134.3%)
|
86.24B
est: 75.47B (+14.3%)
|
84.27B
81.37B – 90.44B
+11.7% YoY
|
94.17B
92.66B – 107.77B
+11.8% YoY
|
104.21B
96.46B – 117.34B
+10.7% YoY
|
113.24B
107.96B – 128.50B
+8.7% YoY
|
135.32B
129.01B – 153.56B
+19.5% YoY
|
| EBIT |
17.54B
est: 16.92B (+3.7%)
|
19.73B
est: 15.65B (+26.1%)
|
15.65B
est: 16.47B (-5.0%)
|
18.40B
est: 17.08B (+7.7%)
|
12.66B
est: 13.95B (-9.2%)
|
21.61B
est: 13.52B (+59.9%)
|
29.74B
est: 19.07B (+55.9%)
|
30.89B
est: 19.15B (+61.3%)
|
34.37B
est: 30.11B (+14.1%)
|
29.39B
est.
|
41.32B
est: 30.55B (+35.3%)
|
53.10B
est: 37.00B (+43.5%)
|
28.96B
est: 38.81B (-25.4%)
|
61.72B
est: 24.65B (+150.4%)
|
61.38B
est: 53.39B (+15.0%)
|
59.62B
57.57B – 63.98B
+11.7% YoY
|
66.63B
65.56B – 76.25B
+11.8% YoY
|
73.73B
68.25B – 83.02B
+10.7% YoY
|
80.11B
76.38B – 90.91B
+8.7% YoY
|
95.74B
91.28B – 108.64B
+19.5% YoY
|
| Net Income |
12.28B
est: 13.26B (-7.4%)
|
12.93B
est: 13.95B (-7.3%)
|
12.79B
est: 14.39B (-11.1%)
|
14.87B
est: 11.53B (+28.9%)
|
8.08B
est: 15.36B (-47.4%)
|
11.05B
est: 14.14B (-21.9%)
|
15.16B
est: 16.42B (-7.7%)
|
21.77B
est: 12.59B (+72.9%)
|
20.95B
est: 16.81B (+24.6%)
|
22.90B
est.
|
23.65B
est: 18.31B (+29.2%)
|
27.80B
est: 22.18B (+25.3%)
|
19.38B
est: 23.27B (-16.7%)
|
35.73B
est: 33.91B (+5.4%)
|
41.67B
est: 28.78B (+44.8%)
|
32.00B
28.27B – 49.27B
+11.2% YoY
|
26.99B
15.22B – 48.90B
-15.7% YoY
|
38.89B
26.93B – 68.95B
+44.1% YoY
|
53.24B
50.01B – 62.56B
+36.9% YoY
|
107.57B
101.05B – 126.42B
+102.1% YoY
|
| SGA |
21.42B
est: 20.57B (+4.1%)
|
2.34B
est: 29.80B (-92.1%)
|
29.94B
est: 37.99B (-21.2%)
|
31.50B
est: 30.36B (+3.7%)
|
32.25B
est: 42.85B (-24.7%)
|
68.21B
est: 34.62B (+97.0%)
|
81.75B
est: 75.46B (+8.3%)
|
91.19B
est: 87.83B (+3.8%)
|
90.92B
est: 100.74B (-9.7%)
|
105.84B
est.
|
80.84B
est: 87.84B (-8.0%)
|
90.16B
est: 106.39B (-15.3%)
|
95.87B
est: 111.60B (-14.1%)
|
97.58B
est: 57.97B (+68.3%)
|
102.26B
est: 120.82B (-15.4%)
|
134.92B
130.27B – 144.79B
+11.7% YoY
|
150.77B
148.34B – 172.54B
+11.8% YoY
|
166.83B
154.43B – 187.86B
+10.7% YoY
|
181.29B
172.83B – 205.72B
+8.7% YoY
|
216.64B
206.54B – 245.84B
+19.5% YoY
|
| EPS |
8.02
est: 8.36 (-4.0%)
|
8.41
est: 8.24 (+2.1%)
|
8.28
est: 10.14 (-18.3%)
|
9.61
est: 7.63 (+26.0%)
|
5.21
est: 9.63 (-45.9%)
|
5.57
est: 6.43 (-13.3%)
|
7.64
est: 6.32 (+20.9%)
|
10.97
est: 6.44 (+70.2%)
|
10.55
est: 8.52 (+23.8%)
|
9.69
est.
|
11.91
est: 10.52 (+13.2%)
|
14.00
est: 14.56 (-3.9%)
|
9.76
est: 12.68 (-23.0%)
|
17.98
est: 13.80 (+30.3%)
|
17.00
est: 14.25 (+19.3%)
|
12.89
11.39 – 19.85
-9.5% YoY
|
10.88
6.13 – 19.70
-15.7% YoY
|
15.67
10.85 – 27.78
+44.1% YoY
|
21.45
20.15 – 25.21
+36.9% YoY
|
43.34
40.71 – 50.93
+102.1% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-11 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-08 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-07 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-06 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-05 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-15 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Narotam Satyanarayan Sekhsaria | Principal Founder & Chairman Emeritus | 2M | male |
| John Varghese | Chief People Officer | — | male |
| Manish Vinodchandra Mistry | Company Secretary & Compliance Officer | — | male |
| Praveen Kumar Garg | Chief Logistics Officer | — | male |
| Rohit Soni | Chief Financial Officer | — | male |
| Sanjay Gupta | Chief Procurement Officer | — | male |
| Sanjay Kumar Behl | Head Sales, Marketing & Logistics | — | male |
| Vineet Bose | Chief Legal Officer | — | male |
| Deepak Balwani | Head of Investor Relations | — | male |
| Vinod Mohanlal Bahety | Chief Executive Officer & Whole-Time Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for AMBUJACEM.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
